Yablonka Uri has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 40000 shares of BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) on January 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 40000 | $0.00 | 48,464.0000 | 5,021,798 | 472.59% | 0.80% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 20000 | $0.00 | 68,464.0000 | 5,021,798 | 41.27% | 0.40% |
| March 11, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 109426 | $0.00 | 126,969.0000 | 2,871,729 | 623.76% | 3.81% |